echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Sun Chunlan emphasized speeding up the research and development of new crown therapeutic drugs during the investigation of the Drug Evaluation Center to provide strong support for the protection of people's health

    Sun Chunlan emphasized speeding up the research and development of new crown therapeutic drugs during the investigation of the Drug Evaluation Center to provide strong support for the protection of people's health

    • Last Update: 2021-11-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Xinhua News Agency, Beijing, October 19th.
    Sun Chunlan, member of the Political Bureau of the CPC Central Committee and Vice Premier of the State Council, visited the Drug Evaluation Center of the State Drug Administration on the 19th to learn about the clinical trials and review services of new coronavirus drugs, and held relevant enterprise and Expert seminars to listen to opinions and suggestions on drug research and development work
    .


    Sun Chunlan emphasized that it is necessary to thoroughly implement the spirit of General Secretary Xi Jinping’s important instructions on epidemic prevention and control and drug research and development, implement the decisions and deployments of the Party Central Committee and the State Council, respect science, follow the rules, concentrate scientific research forces, and fully develop new crown therapeutic drug research and development, and strive for an early date A breakthrough has been made to provide strong support for scientifically preventing and controlling the epidemic and safeguarding people’s health


    State Councilor and Secretary-General of the State Council Xiao Jie attended relevant activities
    .

    Since the outbreak of the new crown pneumonia epidemic, relevant enterprises, scientific research units and scientific and technical personnel have overcome difficulties and continued to tackle key problems.
    Related departments have conducted joint research and review and provided advanced services, actively promoted multi-path drug research and development, quickly selected multiple therapeutic drugs, and launched the "three drugs and three prescriptions.
    " A variety of drugs or therapies are included in the diagnosis and treatment plan, and 31 drugs have entered clinical trials, which have played an important role in consolidating the results of epidemic prevention and control, effectively increasing the cure rate, and reducing the mortality rate
    .


    Sun Chunlan pointed out that effective drugs are the key means to reduce disease hazards and prevent and control the epidemic


    Sun Chunlan emphasized that it is necessary to organize experts to carefully select existing research and development drugs, provide classification support and guidance, and promptly promote approval and listing for complete clinical data; early intervention support for clear mechanism of action, obvious potential efficacy, and good safety Carry out clinical trials
    .


    It is necessary to coordinate domestic and foreign clinical trials, strengthen the construction of domestic clinical research platforms and effective use of clinical resources, guide enterprises to do overseas clinical research in an orderly manner, and accelerate the progress of trials


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.